United Therapeutics EVP, General Counsel Paul Mahon sells 8,300 shares for $4.8 million
Share
Listen to the news
United Therapeutics EVP, General Counsel Paul Mahon sells 8,300 shares for $4.8 million
  • United Therapeutics EVP, General Counsel Paul A. Mahon exercised stock options for 8,300 shares on April 16, 2026 at USD 146.03 per share.
  • Mahon sold 8,300 shares on April 16, 2026 in multiple trades at weighted average prices of about USD 574.03 to USD 578.21.
  • He ended day with 45,172 United Therapeutics shares owned directly.
  • Mahon also held 8,600 stock options following transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231589-26-000010), on April 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending